DUBLIN–(BUSINESS WIRE)–The “2023 Controlled & Modified Drug Release Summit” conference has been added to ResearchAndMarkets.com’s offering.
The next generation of drug and therapeutic delivery is here.
Attend and connect with 160+ senior drug development innovators this May and uncover the industry’s latest formulation and delivery technologies for improving drug product performance and developing next-gen products.
Uncover a multitude of new product development strategies, formulation approaches, and delivery technologies in just 2 days. Likewise, access all session content for your team post-Summit via our on-demand portal. Benefit from 30+ expert sessions and panels including:
- Targeted and Modified Delivery of Molecules: A Patient-Centric Journey
- Nucleic Acid Delivery for Enabling MRNA: Enabling the Next Generation of Therapeutics
- Using Modeling to Design Better Sustained Release Formulations
- Challenges Associated with Melt-Extruded Controlled Release Dosage Forms
- Optimizing Formulation Development for Oral Modified Release Drug Products
- Achieving a Sustained Release Profile in Drug Discovery
- Exploring Opportunities for Sustained Release Long-Acting Injectables:
- MED 3D Printing for Oral Modified Release Products
- Advances in Ocular Delivery: Examining Multiple Drug Modalities and Pre-Clinical Models
- Overcoming Bioavailability Challenges of Peptide-Based Drug Product Development
2022’s Speakers Included:
Pratik Saha, PhD
Director, Biopharmaceutics, Pharmaceutical Development
GlaxoSmithKline
Dipen Desai, PhD
Vice President, Complex Product Development
Amneal
Arijit Chakravarty, PhD
Chief Executive Officer
Fractal Therapeutics
Arul Joseph, PhD
Senior Director, CMC Pharmaceutical Dev
Otsuka Pharmaceuticals
Ramesh Palaparthy, PhD
Executive Director, Clinical Pharmacology
Gilead Sciences
Mikhail Murashov, PhD
Senior Scientist, Preclinical Development
Merck & Co.
Gillie Roth, PhD
Scientist, Preclinical & Translational PKPD
Genentech
Ingrid Liu, PhD
Senior Scientist, Oral Formulation Sciences
Merck & Co.
Wenzhan Yang, PhD
Senior Scientist, Pharmaceutical Development
AstraZeneca
Debanjan Das, PhD
Senior Associate Director & Science Fellow
Bayer
Hamsini Dhoolypala, PhD
Senior Associate Scientist, Pharmacokinetics
Amgen
Xiaoling Li, PhD
Co-Founder & CEO
Triasek
Iriny Ekladious, PhD
Associate Principal Scientist, Sterile and Specialty Products
Merck & Co.
Santipharp Panmai, PhD
Vice President and Head of Early-phase Formulation Development
WuXi STA
Nitin Swarnakar, PhD
North American Pharma Applications Manage
BASF
For more information about this conference visit https://www.researchandmarkets.com/r/tg4vn
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900